These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4795227)

  • 41. [The adriblastin-methotrexate combination in inoperable lung tumors].
    Rimoldi R
    G Ital Chemioter; 1975; 22(1-2):9-10. PubMed ID: 1235360
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of regional versus systemic chemotherapy with adriamycin.
    Didolkar MS; Kanter PM; Baffi RR; Schwartz HS; Lopez R
    Ann Surg; 1978 Mar; 187(3):332-6. PubMed ID: 637593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses.
    Chen HS; Gross JF
    Cancer Treat Rep; 1980 Jan; 64(1):31-40. PubMed ID: 6155210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T; Shibata H; Sampi K; Hirota Y; Yoshida Y; Chiba Y; Shirakawa S; Kobayashi T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Status of adriamycin in cancer therapy].
    Berndt H
    Arch Geschwulstforsch; 1982; 52(7):585-96. PubMed ID: 7165492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases.
    Tan C; Etcubanas E; Wollner N; Rosen G; Gilladoga A; Showel J; Murphy ML; Krakoff IH
    Cancer; 1973 Jul; 32(1):9-17. PubMed ID: 4352019
    [No Abstract]   [Full Text] [Related]  

  • 48. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y; Yoshida Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of Adriamycin and mehtotrexate in carcinoma of the cervix. The development of a safe effective regimen.
    Guthrie D; Way S
    Obstet Gynecol; 1978 Sep; 52(3):349-54. PubMed ID: 309102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intra-arterial chemotherapy for recurrent neoplasms.
    Tindel S
    JAMA; 1967 Jun; 200(11):913-7. PubMed ID: 5297929
    [No Abstract]   [Full Text] [Related]  

  • 51. Adriamycin in the treatment of childhood solid tumors. A Southwest Oncology Group study.
    Ragab AH; Sutow WW; Komp DM; Starling KA; Lyon GM; George S
    Cancer; 1975 Nov; 36(5):1567-76. PubMed ID: 1192348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. INTRA-ARTERIAL INFUSION FOR HEAD AND NECK CANCER.
    JESSE RH; VILLARREAL R; LETAYF V; RUFINO C; HICKEY RC
    Arch Surg; 1964 Apr; 88():618-27. PubMed ID: 14107013
    [No Abstract]   [Full Text] [Related]  

  • 54. Advanced carcinoma of bladder: treatment using hypogastric artery infusion with 5-fluorouracil, either as a single agent or in combination with bleomycin or adriamycin and supervoltage radiation.
    Nevin JE; Melnick I; Baggerly JT; Easley CA; Landes R
    J Urol; 1974 Dec; 112(6):752-8. PubMed ID: 4140242
    [No Abstract]   [Full Text] [Related]  

  • 55. Doxorubicin (Adriamycin)--a new anticancer drug.
    Med Lett Drugs Ther; 1975 May; 17(10):42-3. PubMed ID: 1055286
    [No Abstract]   [Full Text] [Related]  

  • 56. The variability of individual tolerance to methotrexate in cancer patients.
    Hansen HH; Selawry OS; Holland JF; McCall CB
    Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
    Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR
    Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
    Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
    Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chemotherapy of hepatocellular carcinoma--with special reference to one-shot intra-arterial infusion of a high dose of adriamycin].
    Hirose H; Aoyama M; Oshima K; Udo K; Kobayashi S; Adachi N; Nonaka T; Yamada T
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2216-21. PubMed ID: 6307182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
    Chauvergne J; Fumoleau P; Cappelaere P; Metz R; Armand JP; Chevallier B; Kerbrat P; de Forni M; Lhommé C; Roche H
    Eur J Cancer; 1993; 29A(3):350-4. PubMed ID: 8398333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.